DesRosier Thomas (CIK 0001435744)

Latest company ownership

Shares held
112
Last filed at
Nov 18, 2025
Confidence Score
50.6
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 15, 2025 Nov 18, 2025 Seres Therapeutics, Inc. Officer Sell 52.5 -76 -0.99% $1.3K
Aug 15, 2025 Aug 19, 2025 Seres Therapeutics, Inc. Officer Sell 50.0 -76 -1.01% $1.3K
May 15, 2025 May 19, 2025 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 50.0 -79 -1.07% $575.1
Feb 15, 2025 Feb 19, 2025 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 46.3 -4,300 -2.93% $3.5K
Nov 15, 2024 Nov 19, 2024 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 52.5 -878 -0.65% $474.7
Oct 27, 2024 Oct 29, 2024 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 42.5 -4,259 -3.09% $2.9K
Aug 15, 2024 Aug 19, 2024 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 52.5 -873 -0.70% $733.3
May 15, 2024 May 17, 2024 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 52.5 -843 -0.68% $792.4
Feb 15, 2024 Feb 16, 2024 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 42.5 -3,939 -3.16% $4.3K
Oct 27, 2023 Oct 31, 2023 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 42.5 -4,156 -3.52% $5.6K
Jan 26, 2019 Jan 29, 2019 Seres Therapeutics, Inc. Chief Legal Officer and EVP Sell 26.3 -5,471 -25.42% $31.5K
Jan 26, 2018 Jan 30, 2018 Seres Therapeutics, Inc. Officer Sell 26.3 -3,475 -34.75% $38.3K